Ameriprise Financial Inc Delcath Systems, Inc. Transaction History
Ameriprise Financial Inc
- $415 Billion
- Q3 2025
A detailed history of Ameriprise Financial Inc transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 43,237 shares of DCTH stock, worth $386,106. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,237
Previous 28,363
52.44%
Holding current value
$386,106
Previous $385,000
20.52%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DCTH
# of Institutions
130Shares Held
13MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...